血液検査の世界市場見通し2017-2023

◆英語タイトル:Blood Screening - Global Market Outlook (2017-2023)
◆商品コード:SMRC71002027
◆発行会社(調査会社):Stratistics MRC
◆発行日:2017年9月
◆ページ数:168
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥464,800見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥588,000見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、血液検査の世界市場について調査・分析し、血液検査の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 血液検査の世界市場:市場動向分析
- 血液検査の世界市場:競争要因分析
- 血液検査の世界市場:技術別
・次世代シーケンシング(NGS)
・迅速試験
・ウエスタンブロット解析
・酵素結合免疫吸着測定法(ELISA)
・核酸増幅検査(NAT)

- 血液検査の世界市場:製品・サービス別
・ソフトウェア・サービス
・器具
・試薬・検査キット


- 血液検査の世界市場:用途別
・糖尿病血液検査
・心血管疾患血液検査
・癌血液検査
・血液疾患血液検査
・自己免疫疾患および食物アレルギー検査
・妊娠血液検査
・肝疾患血液検査
・腎疾患血液検査
・家庭モニタリング血液検査
・不妊症血液検査

- 血液検査の世界市場:エンドユーザー別
・血液バンク
・病院

- 血液検査の世界市場:主要地域別分析
- 血液検査の北米市場規模(アメリカ市場等)
- 血液検査のヨーロッパ市場規模
- 血液検査のアジア市場規模(日本市場、中国市場、インド市場等)
・血液検査の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Blood Screening market is expected to grow from $1.84 billion in 2016 to reach $3.97 billion by 2023 with a CAGR of 11.6%. Growing incidence of infectious diseases, rise in consciousness of donating blood, and increase in health care awareness are some of the factors boosting the market growth. In addition, technological advancements in blood screening techniques, increasing investments in research & development are some of the other factors fuelling the market growth during the forecast period. However, threat from substitute techniques, initial investment costs are some of the restraints limiting the market growth.

Blood Screening tests are the foundation of a successful health care system, providing critical information that health care provider and patients need to make the right medical decisions. Blood screening often provide objective, quantitative measurements that inform every stage of care—prevention, detection, diagnosis, treatment, and successful management of health conditions.

North America accounted for the largest share in global blood screening market followed by Europe. Growth of the region is attributed to existence of major companies and developed healthcare infrastructure. Asia Pacific is expected to witness huge growth due to developing economies, raising health care expenditure, and increasing demand for blood screening in emerging countries such as China, Japan and India.

Some of the key players in global blood screening market include Abbott Laboratories, Alere Inc., Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hemosense Inc., Luminex Corp., Nova Biomedical Corp., Ortho Clinical Diagnostics, Inc., Roche Diagnostics, Siemens Healthineers (A Subsidiary of Siemens AG), Thermo Fisher Scientific, Inc., and Trinity Biotech.

Technologies Covered:
• Next-generation Sequencing (NGS)
• Rapid Tests
• Western Blot Assay
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Nucleic Acid Test (NAT)

Product & Service Types Covered:
• Software and Services
• Instruments
• Reagents & Kits

Applications Covered:
• Diabetes Blood Testing
• Cardiovascular Disease Blood Testing
• Cancer Blood Testing
• Blood Disorder Blood Testing
• Autoimmune Disease And Food Allergy Testing
• Pregnancy Blood Testing
• Liver Disorder Blood Testing
• Kidney Disorder Blood Testing
• Home-Monitoring Blood Testing
• Fertility Blood Testing

End Users Covered:
• Blood Banks
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Blood Screening Market, By Technology
5.1 Introduction
5.2 Next-generation Sequencing (NGS)
5.3 Rapid Tests
5.4 Western Blot Assay
5.5 Enzyme-Linked Immunosorbent Assay (ELISA)
5.5.1 By Platform
5.5.1.1 Fluorescence Immunoassay (FIA)
5.5.1.2 Colorimetric Immunoassay (CI)
5.5.1.3 Chemiluminescence Immunoassay (CLIA)
5.5.2 By Generation
5.5.2.1 First Generation
5.5.2.2 Second Generation
5.5.2.3 Third Generation
5.5.2.4 Fourth Generation & Above
5.6 Nucleic Acid Test (NAT)
5.6.1 Real-Time Polymerase Chain Reaction (PCR)
5.6.2 Transcription-Mediated Amplification (TMA)

6 Global Blood Screening Market, By Product & Service
6.1 Introduction
6.2 Software and Services
6.3 Instruments
6.3.1 Outright Purchase
6.3.2 Rental Purchase
6.4 Reagents & Kits
6.4.1 ELISA Reagents & Kits
6.4.1.1 Conjugates
6.4.1.2 Controls
6.4.1.3 Immunosorbents
6.4.1.4 Sample Diluents and Wash Solutions
6.4.1.5 Substrates
6.4.2 NAT Reagents & Kits
6.4.2.1 Buffers, Nucleotides, and Solutions
6.4.2.2 Enzymes and Polymerases
6.4.2.3 Labeling and Detection Reagents
6.4.2.4 Probes and Primers
6.4.2.5 Standards and Controls
6.4.3 Other Reagents & Kits

7 Global Blood Screening Market, By Application
7.1 Introduction
7.2 Diabetes Blood Testing
7.3 Cardiovascular Disease Blood Testing
7.4 Cancer Blood Testing
7.5 Blood Disorder Blood Testing
7.6 Autoimmune Disease And Food Allergy Testing
7.7 Pregnancy Blood Testing
7.8 Liver Disorder Blood Testing
7.9 Kidney Disorder Blood Testing
7.10 Home-Monitoring Blood Testing
7.11 Fertility Blood Testing

8 Global Blood Screening Market, By End User
8.1 Introduction
8.2 Blood Banks
8.3 Hospitals

9 Global Blood Screening Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbott Laboratories
11.2 Alere Inc.
11.3 Apex Biotechnology Corp.
11.4 Beckman Coulter (A Subsidiary of Danaher Corporation)
11.5 Becton, Dickinson and Company
11.6 Biomérieux
11.7 Bio-Rad Laboratories, Inc.
11.8 F. Hoffmann-La Roche
11.9 Grifols
11.10 Hemosense Inc.
11.11 Luminex Corp.
11.12 Nova Biomedical Corp.
11.13 Ortho Clinical Diagnostics, Inc.
11.14 Roche Diagnostics
11.15 Siemens Healthineers (A Subsidiary of Siemens AG)
11.16 Thermo Fisher Scientific, Inc.
11.17 Trinity Biotech

List of Tables
Table 1 Global Blood Screening Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 3 Global Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 4 Global Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 5 Global Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 6 Global Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 7 Global Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 8 Global Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 9 Global Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 10 Global Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 11 Global Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 12 Global Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 13 Global Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 14 Global Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 15 Global Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 16 Global Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 17 Global Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 18 Global Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 19 Global Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 20 Global Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 21 Global Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 22 Global Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 23 Global Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 24 Global Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 25 Global Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 26 Global Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 27 Global Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 28 Global Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 29 Global Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 30 Global Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 31 Global Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 32 Global Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 33 Global Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 34 Global Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)
Table 35 North America Blood Screening Market Outlook, By Country (2014-2023) ($MN)
Table 36 North America Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 37 North America Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 38 North America Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 39 North America Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 40 North America Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 41 North America Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 42 North America Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 43 North America Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 44 North America Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 45 North America Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 46 North America Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 47 North America Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 48 North America Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 49 North America Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 50 North America Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 51 North America Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 52 North America Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 53 North America Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 54 North America Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 55 North America Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 56 North America Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 57 North America Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 58 North America Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 59 North America Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 60 North America Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 61 North America Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 62 North America Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 63 North America Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 64 North America Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 65 North America Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 66 North America Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 67 North America Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 68 North America Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)
Table 69 Europe Blood Screening Market Outlook, By Country (2014-2023) ($MN)
Table 70 Europe Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 71 Europe Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 72 Europe Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 73 Europe Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 74 Europe Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 75 Europe Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 76 Europe Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 77 Europe Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 78 Europe Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 79 Europe Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 80 Europe Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 81 Europe Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 82 Europe Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 83 Europe Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 84 Europe Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 85 Europe Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 86 Europe Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 87 Europe Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 88 Europe Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 89 Europe Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 90 Europe Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 91 Europe Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 92 Europe Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 93 Europe Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 94 Europe Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 95 Europe Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 96 Europe Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 97 Europe Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 98 Europe Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 99 Europe Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 100 Europe Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 101 Europe Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 102 Europe Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)
Table 103 Asia Pacific Blood Screening Market Outlook, By Country (2014-2023) ($MN)
Table 104 Asia Pacific Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 105 Asia Pacific Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 106 Asia Pacific Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 107 Asia Pacific Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 108 Asia Pacific Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 109 Asia Pacific Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 110 Asia Pacific Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 111 Asia Pacific Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 112 Asia Pacific Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 113 Asia Pacific Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 114 Asia Pacific Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 115 Asia Pacific Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 116 Asia Pacific Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 117 Asia Pacific Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 118 Asia Pacific Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 119 Asia Pacific Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 120 Asia Pacific Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 121 Asia Pacific Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 122 Asia Pacific Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 123 Asia Pacific Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 124 Asia Pacific Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 125 Asia Pacific Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 126 Asia Pacific Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 127 Asia Pacific Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 128 Asia Pacific Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 129 Asia Pacific Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 130 Asia Pacific Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 131 Asia Pacific Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 132 Asia Pacific Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 133 Asia Pacific Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 134 Asia Pacific Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 135 Asia Pacific Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 136 Asia Pacific Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)
Table 137 South America Blood Screening Market Outlook, By Country (2014-2023) ($MN)
Table 138 South America Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 139 South America Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 140 South America Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 141 South America Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 142 South America Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 143 South America Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 144 South America Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 145 South America Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 146 South America Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 147 South America Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 148 South America Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 149 South America Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 150 South America Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 151 South America Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 152 South America Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 153 South America Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 154 South America Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 155 South America Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 156 South America Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 157 South America Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 158 South America Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 159 South America Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 160 South America Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 161 South America Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 162 South America Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 163 South America Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 164 South America Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 165 South America Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 166 South America Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 167 South America Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 168 South America Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 169 South America Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 170 South America Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)
Table 171 Middle East & Africa Blood Screening Market Outlook, By Country (2014-2023) ($MN)
Table 172 Middle East & Africa Blood Screening Market Outlook, By Technology (2014-2023) ($MN)
Table 173 Middle East & Africa Blood Screening Market Outlook, By Next-generation Sequencing (NGS) (2014-2023) ($MN)
Table 174 Middle East & Africa Blood Screening Market Outlook, By Rapid Tests (2014-2023) ($MN)
Table 175 Middle East & Africa Blood Screening Market Outlook, By Western Blot Assay (2014-2023) ($MN)
Table 176 Middle East & Africa Blood Screening Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2014-2023) ($MN)
Table 177 Middle East & Africa Blood Screening Market Outlook, By Platform (2014-2023) ($MN)
Table 178 Middle East & Africa Blood Screening Market Outlook, By Generation (2014-2023) ($MN)
Table 179 Middle East & Africa Blood Screening Market Outlook, By Nucleic Acid Test (NAT) (2014-2023) ($MN)
Table 180 Middle East & Africa Blood Screening Market Outlook, By Real-Time Polymerase Chain Reaction (PCR) (2014-2023) ($MN)
Table 181 Middle East & Africa Blood Screening Market Outlook, By Transcription-Mediated Amplification (TMA) (2014-2023) ($MN)
Table 182 Middle East & Africa Blood Screening Market Outlook, By Product & Service (2014-2023) ($MN)
Table 183 Middle East & Africa Blood Screening Market Outlook, By Software and Services (2014-2023) ($MN)
Table 184 Middle East & Africa Blood Screening Market Outlook, By Instruments (2014-2023) ($MN)
Table 185 Middle East & Africa Blood Screening Market Outlook, By Outright Purchase (2014-2023) ($MN)
Table 186 Middle East & Africa Blood Screening Market Outlook, By Rental Purchase (2014-2023) ($MN)
Table 187 Middle East & Africa Blood Screening Market Outlook, By Reagents & Kits (2014-2023) ($MN)
Table 188 Middle East & Africa Blood Screening Market Outlook, By ELISA Reagents & Kits (2014-2023) ($MN)
Table 189 Middle East & Africa Blood Screening Market Outlook, By NAT Reagents & Kits (2014-2023) ($MN)
Table 190 Middle East & Africa Blood Screening Market Outlook, By Other Reagents & Kits (2014-2023) ($MN)
Table 191 Middle East & Africa Blood Screening Market Outlook, By Application (2014-2023) ($MN)
Table 192 Middle East & Africa Blood Screening Market Outlook, By Diabetes Blood Testing (2014-2023) ($MN)
Table 193 Middle East & Africa Blood Screening Market Outlook, By Cardiovascular Disease Blood Testing (2014-2023) ($MN)
Table 194 Middle East & Africa Blood Screening Market Outlook, By Cancer Blood Testing (2014-2023) ($MN)
Table 195 Middle East & Africa Blood Screening Market Outlook, By Blood Disorder Blood Testing (2014-2023) ($MN)
Table 196 Middle East & Africa Blood Screening Market Outlook, By Autoimmune Disease And Food Allergy Testing (2014-2023) ($MN)
Table 197 Middle East & Africa Blood Screening Market Outlook, By Pregnancy Blood Testing (2014-2023) ($MN)
Table 198 Middle East & Africa Blood Screening Market Outlook, By Liver Disorder Blood Testing (2014-2023) ($MN)
Table 199 Middle East & Africa Blood Screening Market Outlook, By Kidney Disorder Blood Testing (2014-2023) ($MN)
Table 200 Middle East & Africa Blood Screening Market Outlook, By Home-Monitoring Blood Testing (2014-2023) ($MN)
Table 201 Middle East & Africa Blood Screening Market Outlook, By Fertility Blood Testing (2014-2023) ($MN)
Table 202 Middle East & Africa Blood Screening Market Outlook, By End User (2014-2023) ($MN)
Table 203 Middle East & Africa Blood Screening Market Outlook, By Blood Banks (2014-2023) ($MN)
Table 204 Middle East & Africa Blood Screening Market Outlook, By Hospitals (2014-2023) ($MN)



★調査レポート[血液検査の世界市場見通し2017-2023] (コード:SMRC71002027)販売に関する免責事項を必ずご確認ください。
★調査レポート[血液検査の世界市場見通し2017-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆